67 related articles for article (PubMed ID: 38455841)
1. Causal inference and machine learning in endocrine epidemiology.
Inoue K
Endocr J; 2024 Jul; ():. PubMed ID: 38972718
[TBL] [Abstract][Full Text] [Related]
2. Recent Developments in Causal Inference and Machine Learning.
Brand JE; Zhou X; Xie Y
Annu Rev Sociol; 2023 Jul; 49():81-110. PubMed ID: 38911356
[TBL] [Abstract][Full Text] [Related]
3. Impact of the PATH Statement on Analysis and Reporting of Heterogeneity of Treatment Effect in Clinical Trials: A Scoping Review.
Selby JV; Maas CCHM; Fireman BH; Kent DM
medRxiv; 2024 May; ():. PubMed ID: 38766150
[TBL] [Abstract][Full Text] [Related]
4. Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials.
Blette BS; Halpern SD; Li F; Harhay MO
Stat Methods Med Res; 2024 May; 33(5):909-927. PubMed ID: 38567439
[TBL] [Abstract][Full Text] [Related]
5. Principal stratification analysis of noncompliance with time-to-event outcomes.
Liu B; Wruck L; Li F
Biometrics; 2024 Jan; 80(1):. PubMed ID: 38281770
[TBL] [Abstract][Full Text] [Related]
6. A BAYESIAN MACHINE LEARNING APPROACH FOR ESTIMATING HETEROGENEOUS SURVIVOR CAUSAL EFFECTS: APPLICATIONS TO A CRITICAL CARE TRIAL.
Chen X; Harhay MO; Tong G; Li F
Ann Appl Stat; 2024 Mar; 18(1):350-374. PubMed ID: 38455841
[TBL] [Abstract][Full Text] [Related]
7. Estimating heterogeneous survival treatment effects of lung cancer screening approaches: A causal machine learning analysis.
Hu L; Lin JY; Sigel K; Kale M
Ann Epidemiol; 2021 Oct; 62():36-42. PubMed ID: 34157399
[TBL] [Abstract][Full Text] [Related]
8. A Bayesian Approach for Estimating the Survivor Average Causal Effect When Outcomes Are Truncated by Death in Cluster-Randomized Trials.
Tong G; Li F; Chen X; Hirani SP; Newman SP; Wang W; Harhay MO
Am J Epidemiol; 2023 Jun; 192(6):1006-1015. PubMed ID: 36799630
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Bayesian semi-parametric G-computation for causal inference in a cohort study with MNAR dropout and death.
Josefsson M; Daniels MJ
J R Stat Soc Ser C Appl Stat; 2021 Mar; 70(2):398-414. PubMed ID: 33692597
[TBL] [Abstract][Full Text] [Related]
11. Causal inference for semi-competing risks data.
Nevo D; Gorfine M
Biostatistics; 2022 Oct; 23(4):1115-1132. PubMed ID: 34969069
[TBL] [Abstract][Full Text] [Related]
12. Estimating heterogeneous survival treatment effect in observational data using machine learning.
Hu L; Ji J; Li F
Stat Med; 2021 Sep; 40(21):4691-4713. PubMed ID: 34114252
[TBL] [Abstract][Full Text] [Related]
13. Effect of Lowering Vt on Mortality in Acute Respiratory Distress Syndrome Varies with Respiratory System Elastance.
Goligher EC; Costa ELV; Yarnell CJ; Brochard LJ; Stewart TE; Tomlinson G; Brower RG; Slutsky AS; Amato MPB
Am J Respir Crit Care Med; 2021 Jun; 203(11):1378-1385. PubMed ID: 33439781
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
